Anna Pavlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anna Pavlova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Nataliia Lukianova
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
2 shared publications - Oleksandr Mushii
Інститут експериментальної патології, онкології і радіобіології ім. Р. Є. Кавецького НАН України, Київ, Україна
2 shared publications - T. V. Zadvornyi
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України, Київ, Україна
2 shared publications - Tetiana Burda
National Academy of Sciences of Ukraine
2 shared publications - Anastasiia Shevchuk
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
1 shared publication - Iurii Vitruk
National Cancer Institute, Kyiv
1 shared publication
Latest Publications
- Open Access
- 26 October 2026
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 20
Stress Hormone-Induced Remodeling of the MMP/TIMP System in Breast Cancer Cells of Different Malignant Potential
Background: Chronic stress may modify breast cancer progression through neuroendocrine regulation of tumor cell behavior and extracellular matrix remodeling. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are key components of proteolytic control associated with invasion and metastatic dissemination. Objectives: To evaluate the effects of adrenaline and dexamethasone as model catecholaminergic and glucocorticoid stress-related factors on MMP and TIMP expression in human breast cancer cells with different malignant potential. Design: Experimental in vitro study using two human breast cancer cell lines with different malignant potential. Methods: MCF-7 and MDA-MB-231 cells were exposed to adrenaline or dexamethasone under previously validated chronic stress-modeling conditions. MMP and TIMP mRNA expression was assessed by qPCR, while protein expression was evaluated by immunocytochemistry using the H-score method. Results: In MDA-MB-231 cells, adrenaline activated a broad MMP transcriptional response involving gelatinases and selected collagenases, whereas protein changes were mainly associated with collagenases. Dexamethasone enhanced gelatinase gene expression in these cells but increased protein levels predominantly within the collagenase and MMP-14, without significant changes in gelatinase protein expression. In MCF-7 cells, adrenaline mainly increased gelatinase and MMP14 transcripts, whereas protein-level changes involved increased MMP-9 and MMP-13 and reduced MMP-1 and MMP-8. Dexamethasone broadly reduced MMP transcript levels but increased several MMP proteins, including MMP-1, MMP-9, MMP-13, and MMP-14. Both hormones reduced TIMP-2 protein levels in both cell lines. In MDA-MB-231 cells, hormonal exposure induced TIMP3 /TIMP-3 expression, absent under control conditions, and reduced TIMP-4 protein levels. In MCF-7 cells, adrenaline increased TIMP3 transcript expression, whereas dexamethasone reduced TIMP3 /TIMP-3 expression and induced detectable TIMP-4 protein expression. Conclusion: Adrenaline and dexamethasone exert distinct effects on the MMP/TIMP expression balance in breast cancer cells, indicating that stress-associated modulation of extracellular matrix remodeling is shaped by both the type of hormonal stimulus and tumor cell phenotype.
- 26 October 2026
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 20
Open AccessStress Hormone-Induced Remodeling of the MMP/TIMP System in Breast Cancer Cells of Different Malignant Potential
Background: Chronic stress may modify breast cancer progression through neuroendocrine regulation of tumor cell behavior and extracellular matrix remodeling. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are key components of proteolytic control associated with invasion and metastatic dissemination. Objectives: To evaluate the effects of adrenaline and dexamethasone as model catecholaminergic and glucocorticoid stress-related factors on MMP and TIMP expression in human breast cancer cells with different malignant potential. Design: Experimental in vitro study using two human breast cancer cell lines with different malignant potential. Methods: MCF-7 and MDA-MB-231 cells were exposed to adrenaline or dexamethasone under previously validated chronic stress-modeling conditions. MMP and TIMP mRNA expression was assessed by qPCR, while protein expression was evaluated by immunocytochemistry using the H-score method. Results: In MDA-MB-231 cells, adrenaline activated a broad MMP transcriptional response involving gelatinases and selected collagenases, whereas protein changes were mainly associated with collagenases. Dexamethasone enhanced gelatinase gene expression in these cells but increased protein levels predominantly within the collagenase and MMP-14, without significant changes in gelatinase protein expression. In MCF-7 cells, adrenaline mainly increased gelatinase and MMP14 transcripts, whereas protein-level changes involved increased MMP-9 and MMP-13 and reduced MMP-1 and MMP-8. Dexamethasone broadly reduced MMP transcript levels but increased several MMP proteins, including MMP-1, MMP-9, MMP-13, and MMP-14. Both hormones reduced TIMP-2 protein levels in both cell lines. In MDA-MB-231 cells, hormonal exposure induced TIMP3 /TIMP-3 expression, absent under control conditions, and reduced TIMP-4 protein levels. In MCF-7 cells, adrenaline increased TIMP3 transcript expression, whereas dexamethasone reduced TIMP3 /TIMP-3 expression and induced detectable TIMP-4 protein expression. Conclusion: Adrenaline and dexamethasone exert distinct effects on the MMP/TIMP expression balance in breast cancer cells, indicating that stress-associated modulation of extracellular matrix remodeling is shaped by both the type of hormonal stimulus and tumor cell phenotype.
- Open Access
- 19 January 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (1) , 55
Features of the spatial organization and qualitative composition of the collagen matrix in prostate cancer
The study examined the features of the spatial organization and qualitative composition of the collagen matrix in prostate cancer (PCa) and the relationship of these parameters with the clinicopathological characteristics of the disease. Morphometric, histochemical (Masson’s trichrome staining, Picrosirius Red staining), and immunohistochemical methods were applied to analyze collagen architecture parameters in tumor tissue samples from 87 patients with stage II–IV PCa. Analysis of the quantitative parameters of the tumor collagen matrix showed that decreased collagen fiber length and width were associated with advanced tumor stages and the presence of metastases in pelvic lymph nodes and/or distant organs. An increase in collagen fiber density and alignment was observed in tumors of patients with metastases and elevated PSA levels. Qualitative assessment demonstrated that collagen fiber maturity (CMI) was lower in patients with metastases, whereas increased CMI values were associated with higher Gleason scores and grade groups. Immunohistochemical findings indicate variability in COL1A1 and COL3A1 expression within the PCa stroma; notably, COL3A1 expression was also detected in tumor cells. Elevated COL1A1 levels were recorded in PCa tissues of patients with T3-category tumors and increased PSA, whereas COL3A1 expression was primarily associated with metastatic status and higher histological grades. Correlation analysis confirmed a strong relationship between quantitative and qualitative parameters of collagen matrix architecture and the clinicopathological features of PCa. The findings suggest that the structural organization and composition of the collagen matrix play an important role in PCa progression and may serve as potential prognostic markers of disease course.
- 19 January 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (1) , 55
Open AccessFeatures of the spatial organization and qualitative composition of the collagen matrix in prostate cancer
The study examined the features of the spatial organization and qualitative composition of the collagen matrix in prostate cancer (PCa) and the relationship of these parameters with the clinicopathological characteristics of the disease. Morphometric, histochemical (Masson’s trichrome staining, Picrosirius Red staining), and immunohistochemical methods were applied to analyze collagen architecture parameters in tumor tissue samples from 87 patients with stage II–IV PCa. Analysis of the quantitative parameters of the tumor collagen matrix showed that decreased collagen fiber length and width were associated with advanced tumor stages and the presence of metastases in pelvic lymph nodes and/or distant organs. An increase in collagen fiber density and alignment was observed in tumors of patients with metastases and elevated PSA levels. Qualitative assessment demonstrated that collagen fiber maturity (CMI) was lower in patients with metastases, whereas increased CMI values were associated with higher Gleason scores and grade groups. Immunohistochemical findings indicate variability in COL1A1 and COL3A1 expression within the PCa stroma; notably, COL3A1 expression was also detected in tumor cells. Elevated COL1A1 levels were recorded in PCa tissues of patients with T3-category tumors and increased PSA, whereas COL3A1 expression was primarily associated with metastatic status and higher histological grades. Correlation analysis confirmed a strong relationship between quantitative and qualitative parameters of collagen matrix architecture and the clinicopathological features of PCa. The findings suggest that the structural organization and composition of the collagen matrix play an important role in PCa progression and may serve as potential prognostic markers of disease course.